fingolimod

FDA Drug Profile — FINGOLIMOD, fingolimod

Drug Details

Generic Name
fingolimod
Brand Names
FINGOLIMOD, fingolimod
Application Number
ANDA208003
Sponsor
Solco Healthcare US, LLC
NDC Codes
2
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Fingolimod capsules are a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. ( 1 )